China Vaccine Market Report, 2007-2009
  • July 2008
  • Hard Copy
  • USD $1,900 $1,330
  • Pages:130
  • Single User License
    (PDF Unprintable)       
  • USD $2,000 $1,400
  • Code:
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,000 $2,100
  • Hard Copy + Single User License
  • USD $2,100 $1,470
      

China is the largest vaccine producer and consumer in the world. According to the statistics of the General Administration of Customs, China's total vaccine import and export volume reached 34,846 tons in the first five months of 2008, of which 7,735 tons were imports, and 27,111 tons were exports. China's total vaccine import and export value in the same period was US$217.52 million, of which US$197.73 million was import value, and US$19.79 million was export value.

In 2007, China's total vaccine import and export volume reached 2,320 tons, of which 1,500 tons were imports, 820 tons were exports. China's total vaccine import and export value hit US$386.79 million, of which US$344.28 million was import value, and US$42.51 million was export value.

China Vaccine Import and Export, 2007
(unit: US$ million)
疫苗.gif

Source: China Customs; ResearchInChina

Based on the authoritative statistics of the National Bureau of Statistics, the State-Owned Assets Supervision and Administration Commission, the State Information Center, the Development Research Center of the State Council, the China Pharmaceutical Association, and the General Administration of Customs, this report makes in-depth analysis on China bio-pharmaceutical industry development, vaccine market, impact of SARS on vaccine market, vaccine import & export, key vaccine markets, key vaccine producers, investment opportunities and also makes forecast on the development trend of China's vaccine industry.

1. China Vaccine Market in Globalization Process 
1.1 Impact of Globalization on China Pharmaceutical Market
1.1.1 Pharmaceutical Industry Restructuring and International Division of Labor
1.1.2 Accelerated Globalization Process of Pharmaceutical Market 
1.1.3 International Status of China Pharmaceutical Industry
1.1.4 Forecast of China Status in Global Pharmaceutical Industry, 2009
1.2.1 China Vaccine Market
1.2.2 Policy on Foreign Capital Entry into China Vaccine Market 
1.2.3 Competition Strategies of Chinese Vaccine Companies
1.3 China Vaccine Market Position in the Global Market

2. China Vaccine Market Development in 2008-2009
2.1 Market Characteristics, 2008 
2.2 Main Vaccines Types, 2008
2.3 Market Structure, 2008
2.4 Market Characteristics, 2008
2.5 Market Development Trend, 2008
2.6 Suggestions for Vaccine Industry Development, 2008

3. Market of Main Varieties of Vaccine, 2008
3.1 China Flu Vaccine Market, 2008
3.1.1 Market Background
3.1.2 Research and Development
3.1.3 Market Size 
3.1.4 Competition 
3.1.5 Market Demand
3.1.6 Key Producers  
3.2 China HBV Vaccine Market
3.2.1 Market Background 
3.2.2 Market Size
3.2.3 Main Products
3.2.3.1 Plasma Derived HB Vaccine 
3.2.3.2 Recombinant HB Vaccine
3.2.3.3 Recombinant Vaccine of HB Virus Surface Antigens(CHO cell)
3.2.3.4 New Type of HBV
3.2..4 Market Price
3.2.5 Key Producers
3.3 China Epidemic Cerebrospinal Meningitis Vaccine Market
3.3.1 Market Background
3.3.2 Market Size 
3.3.2 Key Producers
3.4 China AIDS Vaccine Market 
3.4.1 Market Background
3.4.2 Market Size
3.4.3 Research and Development
3.4.3.1 China Research on AIDS Vaccine
3.4.3.2 Research Direction 
3.4.3.5 Process of Research Projects 
3.5 China Bird Flu Vaccine Market
3.5.1. Market Background
3.5.2 Research and Development
3.5.3 Key Producers
3.6 Other Vaccine Market and Research and Development
3.6.1 Lung Cancer Vaccine 
3.6.1.1 Tumor Cell Vaccine 
3.6.1.2 Anti Tumor Antigen Vaccine
3.6.1.3 Anti-idiotypic Vaccine
3.6.1.4 DNA Vaccine
3.6.1.5 Dendritic Cell Vaccine
3.6.1.6 Peptide Vaccine 
3.6.2 China Measles Vaccine Market 
3.6.3 China Research on Cervical Cancer Vaccine 
3.6.4 China Research on Lupus Erythematosus Vaccine
3.6.5 China Research on Rotavirus Vaccine 
3.6.6 Principle of Tumor Vaccine 
3.7 China Animal Vaccine Market  
3.7.1 Development Advantages  
3.7.1.1 Basis of Demand 
3.7.1.2 Green Barriers: Promotion of Animal Vaccine 
3.7.1.3 Market Background of and Demand for Pet Vaccine 
3.7.1.4 Key Producers  
3.7.2 Research Progress in Vaccine for Animal Use 
3.7.2.1 Research and Development of Animal Virus Vaccine 
3.7.2.2 R&D Bases of China Animal Vaccine 
3.7.2.3 Successful Development of Purified Rabies Vaccine for Human Use
3.7.2.4 Research Progress in Pseudorabies Gene-deleted Vaccine

4. Impact of SARS on Vaccine Market
4.1 Vaccine Market Activated by SARS
4.1.1 Booming of Vaccine Industry
4.1.2 Bottleneck of Vaccine Industry
4.1.3 Research and Development of SARS Vaccine 
4.2 Dispute of SARS Patent and Market
4.3 Patent Protection Measures on Anti SARS Vaccine

5. Import and Export of China Vaccine 
5.1 General Trend of Vaccine Trade
5.3 Vaccine Export Regions Structure 
5.4 Trade Methods Structure of Vaccine 
5.5 Comparison between Imported Vaccine and Homemade Vaccine

6.  China Key Vaccine Producers
6.1 Main Vaccine Companies  
6.1.1 China National Biotech Group Co., Ltd
6.1.1.1 Company Profile  
6.1.1.2 Operation Status
6.1.2 Beijing Tiantan Biological Products Co., Ltd. 
6.1.2.1 Company Profile 
6.1.2.2 Operation Status 
6.1.3 Shanghai Institute of Biological Products
6.1.4 Shenzhen Kangtai Biological Products Co., Ltd
6.1.5 Changchun Changsheng Life Sciences Co., Ltd
6.1.6 Shenzhen Neptunus Bioengineering Co., Ltd
6.1.6.1 Company Profile
6.1.6.2 Operation Status
6.1.7 Guangxi Beisheng Pharmaceutical Co., Ltd.
6.1.7.1 Company Profile
6.1.7.2 Operation Status
6.1.8 Star Lake Bioscience Co., Ltd
6.1.8.1 Company Profile
6.1.8.2 Operation Status
6.1.9 Shanghai Fosun Pharmaceutical (Group) Co., Ltd 
6.1.9.1 Company Profile
6.1.9.2 Operation Status

7. Vaccine Market Development Trend and Forecast, 2009
7.1 Latest Information on Vaccine Research and Development 
7.1.1 Development Trend of New Type of Vaccine 
7.1.2 New Types of Vaccines
7.1.2.1 Sub-unit Vaccine
7.1.2.2 Gene Recombination Vaccine
7.1.2.3 Synthetic Vaccine 
7.1.2.4 Immunoglobulin Carrier Vaccine 
7.1.3 Research and Development of New Type of Vaccine 
7.1.3.1 Vaccine for Prevention of Respiratory Disease
7.1.3.2 Vaccine for Prevention of Digestive Disease
7.1.3.3 Vaccine for Prevention of Arbo Infectious Disease
7.1.4 New Type of Combined Vaccine
7.1.4.1 Development History
7.1.4.2 Applications and Problems of Combined Vaccine
7.1.4.3 Development of Combined Vaccine 
7.1.4.4 Taking Oral Combined Vaccine 
7.1.4.5 Immunity of Measles 
7.1.4.6 Immunity of Mumps
7.1.4.7 Application of Varicella Vaccine 
7.2 Forecast of Varicella Vaccine Market, 2009

8. Operation Status of Biopharmaceutical Industry
8.1 Operation Status, 2007
8.1.1 Output Value and Its Changes, 2007
8.1.2 Sales Revenue and Its Changes, 2007
8.1.3 Total Output Value and Its Changes, 2007
8.1.4 Changes in the Number of Key Producers, 2007
8.1.5 Profit and Its Changes, 2007
8.2 Business Operation of Top Ten Companies, 2007
8.2.1 Changes in Sales Revenue of Top Ten Companies, 2007
8.2.2 Changes in Assets of Top Ten Companies, 2007
8.2.3 Changes in Profit of Top Ten Companies, 2007
8.2.4 Changes in Employees of Top Ten Companies, 2007
Flu Vaccine Proportion in Main Vaccine Market 
Flu Vaccine Producers Overseas 
Flu Vaccine Producer at Home
China Key Vaccine Producers and Products
Virus Vaccine-Split Influenza Virus Vaccine's Dosage Form, Price & Origin, 2008
HB Vaccine Proportion in Main Vaccine Market
Virus Vaccine-Recombinant Vaccine of HB's (CHO cell)Dosage Form, Price & Origin, 2008
Virus Vaccine-Recombinant Vaccine of HB's (Barm) Dosage Form, Price & Origin, 2008
Main HB Vaccine Producers 
Morbidity & Mortality of 27 kinds of Infectious Diseases Reported Statutorily
Main Regions of Epidemic Cerebrospinal Meningitis
Total Volume of Epidemic Cerebrospinal Meningitis Vaccine Put into Anhui Province and Jiangsu Province
Statistics of China HIV-infected Patients
Informed Rate of China HIV-infected Patients
Forecast of China Future AIDS Vaccine Market
Profit Margin of Bird Flue Vaccine
Comparison of Import Value between Anti-serum and Vaccine in 2007-2008
Comparison of Import Volume between Anti-serum and in 2007-2008
Anti-serum and Vaccine Export Value, 2007-2008
Anti-serum and Vaccine Export Volume, 2007-2008
Profitability of Beijing Tiantan Biological Products Co., 2007-2008
Operation Ability of Beijing Tiantan Biological Products Co., 2007-2008
Debt-paying Ability of Beijing Tiantan Biological Products Co., 2007-2008
Capital Structure of Beijing Tiantan Biological Products Co., 2007-2008
Development Ability of Beijing Tiantan Biological Products Co., 2007-2008
Cash Flow of Beijing Tiantan Biological Products Co., 2007-2008
Profitability of Shenzhen Neptunus Bioengineering Co., 2007-2008
Operation Ability of Shenzhen Neptunus Bioengineering Co.,2007-2008
Debt-paying Ability of Shenzhen Neptunus Bioengineering Co., 2007-2008
Capital Structure of Shenzhen Neptunus Bioengineering Co., 2007-2008
Development Ability of Shenzhen Neptunus Bioengineering Co., 2007-2008
Cash Flow of Beijing Shenzhen Neptunus Bioengineering Co., 2007-2008
Profitability of Guangxi Beisheng Pharmaceutical Co.,2007-2008
Operation Ability of Guangxi Beisheng Pharmaceutical Co., 2007-2008
Debt-paying Ability of Guangxi Beisheng Pharmaceutical Co., 2007-2008
Capital Structure of Guangxi Beisheng Pharmaceutical Co.,2007-2008
Development Ability of Guangxi Beisheng Pharmaceutical Co., 2007-2008
Cash Flow of Beijing Guangxi Beisheng Pharmaceutical Co., 2007-2008
Profitability of Star Lake Bioscience Co., 2007-2008
Operation Ability of Star Lake Bioscience Co., 2007-2008
China Top 10 Pharmaceutical Giants, 2007
Hepatitis Vaccine Market Size Forecast, 2009
Vaccine for Children Market Forecast, 2009
Vaccine for Adults and Flu Vaccine Market Forecast,2009
Therapeutic Vaccine Market Size Forecast, 2009

China Vitamin Industry Report,2014-2017

China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total out...

China Chemical Pharmaceutical Industry Report, 2013-2016

Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin of chemical drug preparation industry is generally higher than tha...

China Pharmaceutical Distribution Industry Report, 2013

Thanks to the continuous advancement in new medical reform, China’s pharmaceutical distribution industry has maintained a fairly rapid growth in recent years, with the sales value showed a CAGR of rou...

China Pharmaceutical Glass Packaging Industry Report, 2013-2016

Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceuti...

China Chinese Patent Medicine Industry Report, 2013-2016

Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance...

Global and China Monoclonal Antibody Industry Report, 2013-2017

Currently, monoclonal antibody agents have been successfully used in the treatment of tumors, cancers and other serious diseases as a heavyweight in the biopharmaceutical industry. In 2009-2012, the m...

Global and China Insulin Industry Report, 2013-2017

As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 3...

China Large Volume Parenteral (LVP) Industry Report, 2013-2015

Under the context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which is one of the top five Chinese prepar...

China Independent Clinical Laboratory Industry Report,2013-2015

Restricted by the health care system and the medical inspection level (Chinese firms mainly lag behind foreign counterparts in molecular diagnostics and other special tests), Chinese independent clini...

China Vitamin Industry Report, 2012-2015

As a great power of vitamin production and export, China has long been known as the world’s vitamin production base. In recent years, its vitamin exports on external demand accounted for about 80% of ...

China Pharmaceutical Equipment Industry Report, 2012-2015

Driven by the new GMP certification as well as the brisk downstream demand, China pharmaceutical equipment industry has seen steady progress in sales volume and technological content of products over ...

China Genetic Engineering Drug Industry Report, 2011-2012

China gets a late start in developing genetic engineering drug industry, but has achieved leapfrog advance. At present, China has at least one hundred enterprises involved in genetic engineering drugs...

China Animal Vaccine Industry Report, 2011-2012

Along with the frequent outbreaks of animal epidemics, the government’s increasing investment in epidemic prevention and the implementation of compulsory immunization system, Chinese animal vaccine ma...

China Human Vaccine Industry Report, 2011-2012

After decades of development, China has become one of the major producer and consumers of human vaccine around the world. In 2011, human vaccine manufacturers numbered 38 in China and the lot release ...

China Chemical Pharmaceutical Industry Report, 2011

In Jan.-Aug., 2011, the gross industrial output value of Chinese chemical pharmaceutical industry surged by 24.54% YoY to RMB460.531 billion, up 2.67 percentage points over the same period of last yea...

China Pharmaceutical Equipment Industry Report, 2011-2012

In recent years, Chinese pharmaceutical equipment industry has witnessed significant growth in both product quality and technological content, as well as steady rise of sales volume. According to Chin...

China Animal Vaccine Industry Report, 2010-2011

China animal vaccine industry has been fast-growing. The market maintained an average annual growth rate up to 13.6% in 2006-2010, and reached around RMB 7.5 billion in 2010, up 21.0% YoY. With the in...

China Human Vaccine Industry Report, 2010-2011

With the improvement of economy and people’s disease prevention awareness, China’s human vaccine market has expanded in recent years, growing at a CAGR of 24.0% in 2007-2010. In particular, the market...

2005-2014 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号
在线客服系统